For Darmstadt, Germany’s Merck KGaA, 2023 is shaping up to be another “challenging year,” thanks to a lull in the semiconductor market, decreased demand for COVID-related services and “persistently high inflation,” the company said in its latest earnings report.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,